18F-flurpiridaz positron emission tomography segmental and territory myocardial blood flow metrics: incremental value beyond perfusion for coronary artery disease categorization.
René R Sevag PackardJohn R VotawC David CookeKenneth F Van TrainErnest V GarciaJamshid MaddahiPublished in: European heart journal. Cardiovascular Imaging (2022)
Assessment of segmental MBF metrics with 18F-flurpiridaz is feasible and improves flow-based epicardial CAD detection. When combined with PQ, only SMBF provides additive diagnostic performance in moderate CAD.
Keyphrases
- coronary artery disease
- positron emission tomography
- blood flow
- computed tomography
- percutaneous coronary intervention
- cardiovascular events
- coronary artery bypass grafting
- pet ct
- contrast enhanced
- pet imaging
- left ventricular
- high intensity
- loop mediated isothermal amplification
- label free
- magnetic resonance imaging
- real time pcr
- type diabetes
- heart failure
- magnetic resonance
- acute coronary syndrome
- aortic valve